[Starlight]

Gilead Sciences tops estimates (GILD) 34.56 -0.04: Reports Q3 (Sep) earnings of $0.10 per share, $0.03 better than the Multex consensus of $0.07; revenues rose 163.3% year/year to $134.0 mln vs the $110.9 mln consensus.


MRO Software tops estimates (MROI) 7.29 +0.29: Reports Q4 (Sep) earnings of $0.11 per share, $0.07 better than the Multex consensus of $0.04; revenues fell 9.5% year/year to $46.1 mln vs the $46.0 mln consensus; sees FY03 earnings in the range of $0.30-$0.34 per share -- Multex consensus estimate is for earnings of $0.32 per share.


Caliper Tech tops estimates (CALP) 4.00 +0.11: Company reports net loss of $0.38 per share, $0.06 better than the Multex consensus estimate; revs were $6.6 mln, vs consensus of $6.9 mln; cash, cash equivalents and short-term marketable securities were $126.4 million at September 30, 2002


Noven Pharma beats by a penny (NOVN) 12.81 +0.36: Reports Q3 earnings of $0.12 per share, $0.01 better than the Multex consensus. Revs rose 26.9% year/year to $13.2 mln vs the $12.2 mln consensus.


ChipPAC misses estimates; guides lower (CHPC) 2.63 +0.18: Reports Q3 (Sep) loss of $0.03 per share, $0.01 worse than the Multex consensus of ($0.02); revenues rose 26.8% year/year to $94.7 mln vs the $100.5 mln consensus; expects revenue for the fourth quarter to be in the range of $89 million to $92 million with EPS in the range of ($0.07) to ($0.10) per share -- Multex consensus estimates are for earnings of $0.02 per share and $105.4 million respectively.

weitere Earnings unter Nachbörsliche Quartalsberichte ....

----------------------------------